Navigation Links
Planned Parenthood Director Quits Abortion Business, Experiences Conversion at Starting Place of 40 Days for Life
Date:11/2/2009

BRYAN, Texas, Nov. 2 /PRNewswire-USNewswire/ -- The director of the Planned Parenthood abortion center in Bryan/College Station, Texas has resigned her job. Abby Johnson had worked at the clinic for eight years, but departed from the facility following a profound change of heart about abortion. The Planned Parenthood clinic was the location of the first-ever 40 Days for Life campaign in the fall of 2004, and the prayer and fasting initiative has been held outside the doors of Johnson's former workplace five additional times since 40 Days for Life began its rapid spread to 282 cities across all 50 states and several other countries.

"This amazing conversion demonstrates the importance of a constant, peaceful prayer presence in front of abortion facilities," said David Bereit, national director of 40 Days for Life. "From that first campaign in 2004, we've prayed for Abby - and for all abortion workers - that they would come to see what abortion really is, and that they would leave the deadly business. In this case, those prayers have been answered. We are so proud of Abby's courage to leave the abortion industry and publicly announce her reasons for leaving."

Johnson said, "I left on good terms and simply had a change of heart on this issue. Over the past few months I had seen a change in motivation regarding the financial impact of abortions and really reached my breaking point after witnessing a particular kind of abortion on an ultrasound."

In the wake of her departure, Planned Parenthood has gone to court to seek a restraining order against both Johnson and the Coalition for Life, the local group that originated 40 Days for Life and continued regular prayer vigils in front of the clinic for the past five years. A court hearing on the order, which addresses disclosure of confidential information, is scheduled in a Texas court on November 10.

Shawn Carney, the director of the Coalition for Life and a 40 Days for L
'/>"/>

SOURCE 40 Days for Life
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Section 1803: Senate Health Care Bill Makes Planned Parenthood Quasi-Government Agency? Asks ALL
2. Zargis Cleared as Apple iPhone Developer; Medical Applications for Smartphones Planned
3. Planned Parenthood Advocacy Project Los Angeles County Celebrates Champions of Choice at Politics, Sex & Cocktails
4. Planned Parenthood Kicks Off Sex Ed Week of Action
5. Planned Parenthood Stresses Importance of Regular Checkups During Gynecologic Cancer Awareness Month
6. FRC Actions Tony Perkins Challenges Planned Parenthood President to Debate
7. FRC: The Truth Hurts Planned Parenthood and NARAL
8. New BioTrends Report Explores Anticipated Treatment Pattern Shifts Expected with the Proposed Bundled Payment Structure Planned for 2011
9. FRC Deplores House Vote to Fund Planned Parenthood
10. Schering-Plough Reports Proposed Settlement in Litigation Involving Planned Merger with Merck
11. FRC Says Planned Parenthood, Desperate to Hide Agenda, Attacks Hatch and Hides Intent
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3CompuCyte Announces the Release of Four-Laser Imaging Cytometers 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 1Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 2Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 3Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 4Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 5Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 6Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 7Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 8Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 9Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 10Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 11Nonin Medical Recognized for Influential Contributions in Medical Technology 5845 1Nonin Medical Recognized for Influential Contributions in Medical Technology 5845 2Neuro Kinetics 26amp 3B Military Researchers in Push To Improve Diagnosis 26amp 3B Treatment of Combat Brain Injuries 5842 1Neuro Kinetics 26amp 3B Military Researchers in Push To Improve Diagnosis 26amp 3B Treatment of Combat Brain Injuries 5842 2